Search For "bharat biotech"
AIIMS Delhi to start Covaxin trials on children in few days, say sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
Read More
Bihar: Covaxin trials on children begin at Patna's AIIMS
Updated : 4 years, 9 months ago IST
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
Read More
Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by Ju
Updated : 4 years, 10 months ago IST
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
Read More
Chidambaram seeks CAG-driven audit of vaccine production, says mystery of
Updated : 4 years, 10 months ago IST
New Delhi [India], May 29 (ANI): Congress leader P Chidambaram said on Saturday that the mystery of the "missing vaccines" is deepening every day and a CAG driven full-scope audit of capacity, production, despatch, supply and customers' lists of two domestic manufacturers of COVID-19 vaccin
Read More
Covaxin production takes 120 days depending on technology framework, regul
Updated : 4 years, 10 months ago IST
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech on Friday said that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regulatory
Read More
IIL partners with Bharat Biotech to produce drug substance for Covaxin fro
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 28 (ANI): Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp up the production of the COVID-19 vaccine.
Read More
Rajasthan govt will appeal to SC to direct Centre to float global tenders
Updated : 4 years, 10 months ago IST
Jaipur (Rajasthan) [India], May 27 (ANI): Rajasthan Health Minister Dr Raghu Sharma on Thursday said that the state government will appeal to the Supreme Court to direct the Government of India to issue global tenders and procure COVID-19 vaccines.
Read More
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by
Updated : 4 years, 10 months ago IST
New Delhi [India], May 26 (ANI): COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Septembe
Read More
Bharat Biotech submits 90 pc documentation, confident of WHO emergency use
Updated : 4 years, 10 months ago IST
New Delhi [India], May 24 (ANI): Bharat Biotech is confident about obtaining the World Health Organization's (WHO) Emergency Use Listing for its COVID-19 vaccine given its experience of getting its other vaccines pre-qualified and has submitted 90 per cent of the documentation required for E
Read More
Paediatric trials of Covaxin may begin in June
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Read More
Bharat Biotech to scale up Covaxin production, eyes 200 mn doses annually
Updated : 4 years, 10 months ago IST
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Read More
Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
Read More